Literature DB >> 455304

Kinetic characterization and response to chemotherapy in a transplantable murine ovarian cancer.

R F Ozols, K R Grotzinger, R I Fisher, C E Myers, R C Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455304

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

Review 1.  Developing new drugs for ovarian cancer: a challenging task in a changing reality.

Authors:  R M Canetta; S K Carter
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

2.  Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells.

Authors:  T K Yeo; J A Nagy; K T Yeo; H F Dvorak; B P Toole
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

3.  Preclinical evaluation of aclacinomycin A for the intraperitoneal treatment of human ovarian carcinoma.

Authors:  K G Louie; T C Hamilton; B C Behrens; K R Grotzinger; W M McKoy; C E Myers; R C Young; R F Ozols
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 4.  Intracavitary chemotherapy for malignant disease confined to body cavities.

Authors:  M Markman
Journal:  West J Med       Date:  1985-03

5.  Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients.

Authors:  K Van der Speeten; K Govaerts; O A Stuart; P H Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-06-13       Impact factor: 2.260

Review 6.  Intraperitoneal therapy in the management of ovarian carcinoma.

Authors:  M Markman; T Hakes; B Reichman; W Hoskins; S Rubin; W Jones; L Almadones; J L Lewis
Journal:  Yale J Biol Med       Date:  1989 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.